Mucopolysaccharidoses (MPS) Latest Advances
Find the Latest Research About Mucopolysaccharidoses (MPS)
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3820 publications
Advances in Therapies for Mucopolysaccharidoses.
Journal: Current issues in molecular biology
Published: May 28, 2026
RPE Abnormality Is a Potential Primary Cause for Retinal Degeneration in Mucopolysaccharidosis Type VI Patients and a Rat Model.
Journal: Investigative ophthalmology & visual science
Published: May 18, 2026
Mucopolysaccharidosis type IIIA and IIIC phenotypic progression: A case series.
Journal: Molecular genetics and metabolism reports
Published: May 16, 2026
A Rare Case of Mucopolysaccharidosis Presenting With Dysostosis Multiplex and Preserved Intelligence in a Seven-Year-Old Girl From Northeast India.
Journal: Cureus
Published: May 14, 2026
Personalized Drug Repurposing Screen Identifies Patient-Specific Therapeutic Candidates for Mucopolysaccharidosis Type IIIB.
Journal: Journal of personalized medicine
Published: May 12, 2026
Interim analysis of post-marketing surveillance study of intracerebroventricular idursulfase therapy for neuronopathic mucopolysaccharidosis type II: Safety and effectiveness in clinical practice in Japan.
Journal: Molecular genetics and metabolism
Published: May 08, 2026
Combined Intracerebroventricular Enzyme Replacement and Cord Blood Transplantation in Patients with Mucopolysaccharidosis Type II Diagnosed Through Newborn Screening.
Journal: International journal of neonatal screening
Published: May 07, 2026
Newborn Screening and Early Cord Blood Transplant for Mucopolysaccharidosis.
Journal: JAMA network open
Published: May 04, 2026
Last Updated: 09/19/2026